XML 15 R39.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Reporting and Foreign Operations (Tables)
12 Months Ended
Dec. 31, 2012
Segment Reporting [Abstract]  
Revenue from External Customers by Products and Services [Table Text Block]
Listed below are the sales by business segment for the years ended December 31, 2012, 2011 and 2010 (in thousands):
 
% Change
 
2012
 
% Change
 
2011
 
% Change
 
2010
Cardiovascular
 

 
 

 
 

 
 

 
 

 
 

Stand-alone devices
12
%
 
$
114,242

 
15
%
 
$
101,959

 
16
%
 
$
88,586

Custom kits and procedure trays
3
%
 
94,586

 
11
%
 
91,532

 
11
%
 
82,799

Inflation devices
2
%
 
68,979

 
8
%
 
67,353

 
2
%
 
62,495

Catheters
17
%
 
64,878

 
23
%
 
55,357

 
18
%
 
44,824

Embolization devices
8
%
 
33,870

 
247
%
 
31,229

 
%
 
9,003

CRM/EP
%
 
1,938

 
%
 

 
%
 

Total
9
%
 
378,493

 
21
%
 
347,430

 
15
%
 
287,707

 
 
 
 
 
 
 
 
 
 
 
 
Endoscopy
 

 
 

 
 

 
 

 
 

 
 

Endoscopy devices
31
%
 
15,795

 
33
%
 
12,019

 
18
%
 
9,048

 
 
 
 
 
 
 
 
 
 
 
 
Total
10
%
 
$
394,288

 
21
%
 
$
359,449

 
15
%
 
$
296,755

Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]
Our long-lived assets by geographic area at December 31, 2012, 2011 and 2010, consisted of the following (in thousands):

 
2012
 
2011
 
2010
United States
$
176,644

 
$
134,393

 
$
97,881

Ireland
48,182

 
36,008

 
22,203

Other foreign countries
9,977

 
8,739

 
7,971

 
 
 
 
 
 
Total
$
234,803

 
$
179,140

 
$
128,055

Schedule of Segment Reporting Information, by Segment [Table Text Block]
Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the years ended December 31, 2012, 2011 and 2010, are as follows (in thousands):

 
2012
 
2011
 
2010
Revenues
 

 
 

 
 

Cardiovascular
$
378,493

 
$
347,430

 
$
287,707

Endoscopy
15,795

 
12,019

 
9,048

Total revenues
394,288

 
359,449

 
296,755

 
 
 
 
 
 
Operating expenses
 

 
 

 
 

Cardiovascular
142,089

 
122,600

 
93,884

Endoscopy
10,262

 
9,678

 
9,066

Total operating expenses
152,351

 
132,278

 
102,950

 
 
 
 
 
 
Goodwill impairment charge
 

 
 

 
 

Cardiovascular

 

 

Endoscopy

 

 
8,344

Total goodwill impairment charge

 

 
8,344

 
 
 
 
 
 
Operating income (loss)
 

 
 

 
 

Cardiovascular
30,411

 
38,010

 
30,176

Endoscopy
(770
)
 
(4,820
)
 
(12,972
)
Total operating income
29,641

 
33,190

 
17,204

 
 
 
 
 
 
Total other expense - net
(2,023
)
 
(315
)
 
(416
)
Income tax expense
7,908

 
9,831

 
4,328

 
 
 
 
 
 
Net income
$
19,710

 
$
23,044

 
$
12,460

Reconciliation of Assets from Segment to Consolidated [Table Text Block]
Total assets by business segment at December 31, 2012, 2011 and 2010, consisted of the following (in thousands):

 
2012
 
2011
 
2010
Cardiovascular
$
692,689

 
$
434,747

 
$
355,718

Endoscopy
12,620

 
12,270

 
13,762

 
 
 
 
 
 
Total
$
705,309

 
$
447,017

 
$
369,480

Segment Depreciation And Amortization [Table Text Block]
Total depreciation and amortization by business segment for the years ended December 31, 2012, 2011 and 2010, consisted of the following (in thousands):

 
2012
 
2011
 
2010
 
 
 
 
 
 
Cardiovascular
$
21,441

 
$
18,219

 
$
13,851

Endoscopy
1,093

 
975

 
1,005

Total
$
22,534

 
$
19,194

 
$
14,856

Segment Capital Expenditures [Table Text Block]
Total capital expenditures by business segment for the years ended December 31, 2012, 2011 and 2010, consisted of the following (in thousands):

 
2012
 
2011
 
2010
 
 
 
 
 
 
Cardiovascular
$
64,059

 
$
58,775

 
$
23,494

Endoscopy
584

 
420

 
154

Total
$
64,643

 
$
59,195

 
$
23,648